There is nothing more valuable than human life, and these are not just words, but a firm principle adopted by the Kingdom of Bahrain, leadership and government, for decades. And when a global medical achievement is achieved on its soil, it is not a coincidence, but rather as a result of a clear vision that believes that human health is the basis, and that real development begins with improving the quality of life.
In a historical medical achievement, the Kingdom of Bahrain succeeded through the Bahrain Oncology Center in completing the treatment of a patient with sickle cell anemia through the technique of marrow transplantation using the genetic adjustment “CRISPR”, to be the first person in the world from outside the United States of America to be successfully announced treatment.
This step enhances Bahrain’s leadership in the field of precise medicine and innovative health solutions, and confirms its commitment to ensuring access to the latest medical technologies according to the highest international standards.
The CrisPR technique that was used is one of the latest innovations in the field of genetic engineering, as it depends on adjusting the genes with extreme accuracy, allowing the body to produce healthy red blood cells capable of transporting oxygen efficiently, without causing the clots or pain that suffers from it Patients.
This technique is a revolution in the world of medicine, as it allows the possibility of treating genetic diseases from its roots, rather than only relieving symptoms.
The Kingdom of Bahrain was keen, in line with the visions of His Majesty King Hamad bin Isa Al Khalifa, the King of the Great Country, may God protect and preserve him, and the directives of His Royal Highness Prince Salman bin Hamad Al Khalifa, Crown Prince, Prime Minister, may God protect him, to provide the latest health services And keeping pace with the therapeutic developments that achieve the best levels of sustainable health care.
Bahrain’s adoption of Casgevy – Exa -Cel for sickle cell anemia and beta -beta, as the first country in the Middle East and the second in the world, to confirm its commitment to providing advanced therapeutic solutions after a comprehensive evaluation of safety, quality and effectiveness standards.
His Highness the Crown Prince, the Prime Minister, during his visit to the Coriac Agriculture Unit at the Bahrain Oncology Center, was keen to check on the health of the patient who has completed his treatment, stressing that Bahrain is continuing to develop the health sector and enhance its partnerships with international medical institutions, to ensure the provision of the latest treatments for the people of the country.
This visit carries a great indication of the direct interest that the rational leadership attaches to the development of the health system, which contributes to improving the quality of life and raising the efficiency of medical services provided to citizens.
This achievement reflects the commitment of the Kingdom of Bahrain to adopt health innovation, as it is no longer satisfied with keeping pace with developments, but rather has become a partner in its industry, by investing in advanced medical techniques and enhancing its global partnerships.
After this great achievement, the Bahrain Oncology Center will become an accredited medical destination at the international level in the treatment of genetic blood diseases using accurate medicine techniques, making it a reliable option for many countries looking for these advanced possibilities and experiences.
As Bahrain continues to develop its health strategies, it continues to consolidate its position as a world leading country in providing advanced health care, keeping pace with the latest scientific developments, and contributes to improving the quality of life, not only for its citizens, but for everyone who is looking for a treatment specialized in the highest medical standards.
